Literature DB >> 12169343

Signaling networks in the pathophysiology and treatment of mood disorders.

Todd D Gould1, Husseini K Manji.   

Abstract

Over the past decade, the focus of research into the pathophysiology of mood disorders (bipolar disorder and unipolar depression in particular) has shifted from an interest in the biogenic amines to an emphasis on second messenger systems within cells. Second messenger systems rely on cell membrane receptors to relay information from the extracellular environment to the interior of the cell. Within the cell, this information is processed and altered, eventually to the point where gene and protein expression patterns are changed. There is a preponderance of evidence implicating second messenger systems and their primary contact with the extracellular environment, G proteins, in the pathophysiology of mood disorders. After an introduction to G proteins and second messenger pathways, this review focuses on the evidence implicating G proteins and two second messenger systems-the adenylate cyclase (cyclic adenosine monophosphate, cAMP) and phosphoinositide (protein kinase C, PKC) intracellular signaling cascades-in the pathophysiology and treatment of bipolar disorder and unipolar depression. Emerging evidence implicates changes in cellular resiliency, neuroplasticity and additional cellular pathways in the pathophysiology of mood disorders. The systems discussed within this review have been implicated in neuroplastic processes and in modulation of many other cellular pathways, making them likely candidates for mediators of these findings.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169343     DOI: 10.1016/s0022-3999(02)00426-9

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  30 in total

Review 1.  Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.

Authors:  Jorge A Quiroz; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Neuropsychobiology       Date:  2010-05-07       Impact factor: 2.328

2.  [Bipolar depression. Epidemiology, etiopathogenesis, and course].

Authors:  S Haack; A Pfennig; M Bauer
Journal:  Nervenarzt       Date:  2010-05       Impact factor: 1.214

Review 3.  Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.

Authors:  Rosilla F Bachmann; Robert J Schloesser; Todd D Gould; Husseini K Manji
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

4.  Mood stabilizer psychopharmacology.

Authors:  Todd D Gould; Guang Chen; Husseini K Manji
Journal:  Clin Neurosci Res       Date:  2002-11-14

Review 5.  Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature.

Authors:  Ashwini Saxena; Giselli Scaini; Daniela V Bavaresco; Camila Leite; Samira S Valvassori; André F Carvalho; João Quevedo
Journal:  Mol Neuropsychiatry       Date:  2017-10-07

6.  Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism.

Authors:  Jill D Jacobson; Kathryn A Ellerbeck; Kelsie A Kelly; Kandace K Fleming; T Rene Jamison; Charles W Coffey; Catherine M Smith; R Matthew Reese; Scott A Sands
Journal:  Psychoneuroendocrinology       Date:  2013-11-26       Impact factor: 4.905

7.  Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients.

Authors:  Harold W Koenigsberg; Peixiong Yuan; George A Diaz; Stephanie Guerreri; Christine Dorantes; Sarahjo Mayson; Constantin Zamfirescu; Antonia S New; Marianne Goodman; Husseini K Manji; Larry J Siever
Journal:  Psychiatry Res       Date:  2012-05-26       Impact factor: 3.222

8.  Myo-inositol-1-phosphate (MIP) synthase inhibition: in-vivo study in rats.

Authors:  H Einat; F Tian; R H Belmaker; J W Frost
Journal:  J Neural Transm (Vienna)       Date:  2007-09-10       Impact factor: 3.575

Review 9.  The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.

Authors:  Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Bipolar Disord       Date:  2009-06       Impact factor: 6.744

10.  Carbamazepine extended-release capsules in bipolar disorder.

Authors:  Richard H Weisler
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.